Stantec Inc. (TSE:STN – Get Free Report) (NYSE:STN) Director Vito Culmone purchased 4,000 shares of the stock in a transaction dated Wednesday, November 27th. The stock was acquired at an average cost of C$121.49 per share, with a total value of C$485,960.00.
Stantec Stock Performance
STN stock traded down C$0.53 during trading on Wednesday, reaching C$120.25. The company had a trading volume of 336,469 shares, compared to its average volume of 262,909. The company has a market cap of C$13.72 billion, a price-to-earnings ratio of 39.73, a price-to-earnings-growth ratio of 1.46 and a beta of 0.82. Stantec Inc. has a twelve month low of C$96.31 and a twelve month high of C$122.83. The company has a debt-to-equity ratio of 80.74, a quick ratio of 1.46 and a current ratio of 1.39. The firm has a 50-day simple moving average of C$113.40 and a 200-day simple moving average of C$113.29.
Stantec Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.84 annualized dividend and a dividend yield of 0.70%. Stantec’s payout ratio is currently 27.63%.
Analysts Set New Price Targets
Check Out Our Latest Research Report on STN
Stantec Company Profile
Stantec Inc provides professional services in the areas of infrastructure and facilities to the public and private sectors in Canada, the United States, and internationally. It offers evaluation, planning, and designing infrastructure solutions; solutions for sustainable water resources, planning, management, and infrastructure; environmental services; integrated architecture, engineering, interior design, and planning solutions for buildings; and energy and resources solutions.
Featured Stories
- Five stocks we like better than Stantec
- There Are Different Types of Stock To Invest In
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Analyst Ratings and Canadian Analyst Ratings
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in the FAANG Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Stantec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stantec and related companies with MarketBeat.com's FREE daily email newsletter.